Frequency of KRAS G12C plus co-mutations in solid tumors and adequate test methods

被引：0
|
作者：
Schatz, Stefanie [1 ]
Falk, Markus [1 ]
Tiemann, Markus [1 ]
机构：
[1] Inst Hamatopathol Hamburg, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2022年 / 45卷 / SUPPL 3期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
554
引用
收藏
页码：176 / 176
页数：1
相关论文
共 50 条
  • [1] KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing
    Lim, Tony Kiat Hon
    Skoulidis, Ferdinandos
    Kerr, Keith M.
    Ahn, Myung-Ju
    Kapp, Joshua R.
    Soares, Fernando A.
    Yatabe, Yasushi
    LUNG CANCER, 2023, 184
  • [2] Targeting the KRAS G12C Mutation in Patients With Advanced Solid Tumors
    Hong, David S.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 612 - 614
  • [3] Phase I/II study of D3S-001, a second generation KRAS G12C inhibitor in advanced/metastatic solid tumors with KRAS G12C mutations
    Cho, B. C.
    Lu, S.
    Lee, M. A.
    Song, Z.
    Park, J. J. W.
    Lim, S. M.
    Li, Z.
    Zhao, J.
    Richardson, G.
    Zhang, Y.
    Zhang, J.
    Liu, A.
    Chen, C.
    Wang, J.
    Chen, J.
    Wang, A.
    Zhang, J.
    Chen, Z. G.
    Mok, T. S. K.
    Johnson, M. L.
    ANNALS OF ONCOLOGY, 2024, 35 : S493 - S493
  • [4] Prevalence of KRAS G12C Mutation and Co-mutations and Associated Clinical Outcomes in Patients With Colorectal Cancer: A Systematic Literature Review
    Strickler, John H.
    Yoshino, Takayuki
    Stevinson, Kendall
    Eichinger, Christian Stefan
    Giannopoulou, Christina
    Rehn, Marko
    Modest, Dominik Paul
    ONCOLOGIST, 2023, : E981 - E994
  • [5] LANDSCAPE OF KRAS G12C MUTATIONS IN GENITOURINARY MALIGNANCIES
    Rebecca, Sager A.
    Michael, Basin F.
    Hanan, Goldberg
    Jeffrey, Ross S.
    Gennady, Bratslavsky
    Joseph, Jacob M.
    Petros, Grivas
    Andrea, Necchi
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S69 - S69
  • [6] Circulating Tumor DNA Dynamics Reveal KRAS G12C Mutation Heterogeneity and Response to Treatment with the KRAS G12C Inhibitor Divarasib in Solid Tumors
    Choi, Yoonha
    Dharia, Neekesh V.
    Jun, Tomi
    Chang, Julie
    Royer-Joo, Stephanie
    Yau, Kenneth K.
    Assaf, Zoe J.
    Aimi, Junko
    Sivakumar, Smruthy
    Montesion, Meagan
    Sacher, Adrian
    LoRusso, Patricia
    Desai, Jayesh
    Schutzman, Jennifer L.
    Shi, Zhen
    CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3788 - 3797
  • [7] Targeting KRAS G12C mutations in colorectal cancer
    Zhao, Ming-He
    Wu, Ai-Wen
    GASTROENTEROLOGY REPORT, 2023, 11
  • [8] Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors
    Marinelli, D.
    Pisegna, S.
    Giammaruco, M.
    Chesi, P.
    Mammone, G.
    Ceddia, S.
    Gazzaniga, P.
    Cortesi, E.
    Gelibter, A. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1345 - S1346
  • [9] KRAS G12C Mutations in NSCLC: From Target to Resistance
    Addeo, Alfredo
    Banna, Giuseppe Luigi
    Friedlaender, Alex
    CANCERS, 2021, 13 (11)
  • [10] Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation
    Sacher, Adrian
    LoRusso, Patricia
    Patel, Manish R.
    Miller, Wilson H.
    Garralda, Elena
    Forster, Martin D.
    Santoro, Armando
    Falcon, Alejandro
    Kim, Tae Won
    Paz-Ares, Luis
    Bowyer, Samantha
    de Miguel, Maria
    Han, Sae-Won
    Krebs, Matthew G.
    Lee, Jong-Seok
    Cheng, Michael L.
    Arbour, Kathryn
    Massarelli, Erminia
    Choi, Yoonha
    Shi, Zhen
    Mandlekar, Sandhya
    Lin, Mark T.
    Royer-Joo, Stephanie
    Chang, Julie
    Dharia, Neekesh V.
    Schutzman, Jennifer L.
    Desai, Jayesh
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (08): : 710 - 721
12345